Herpes simplex virus glycoprotein immunotherapy of recurrent genital herpes: Factors influencing efficacy
- 1 May 1989
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 11 (4), 203-214
- https://doi.org/10.1016/0166-3542(89)90005-3
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Antibody to cloned HSV glycoproteins B and D plus adult human leukocytes protect neonatal mice from lethal HSV infectionAntiviral Research, 1988
- Herpes simplex virus glycoprotein treatment of recurrent genital herpes reduces cervicovaginal virus shedding in guinea pigsAntiviral Research, 1988
- Efficacy of Recombinant Glycoprotein D Subunit Vaccines on the Development of Primary, Recurrent, and Latent Genital Infections with Herpes Simplex Virus Type 2 in Guinea PigsThe Journal of Infectious Diseases, 1988
- Effect of liposome encapsulated recombinant herpes simplex glycoprotein in controlling recurrent herpes genitalis : R.J.Y. Ho∗, R.L. Burke+, and T.C. Merigan∗. Department of Medicine, ∗Division of Infectious Diseases, Stanford University School of Medicine, Stanford, California 94605, and +Department of Virology, Chiron Corporation, 4560 Horton Street, Emeryville, California 94608, U.S.A.Antiviral Research, 1988
- Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital HerpesThe Journal of Infectious Diseases, 1988
- Vaccination with Recombinant Herpes Simplex Virus Glycoproteins: Protection Against Initial and Recurrent Genital HerpesThe Journal of Infectious Diseases, 1987
- The quest for a herpes simplex virus vaccine: background and recent developmentsVaccine, 1986
- Infections with Herpes Simplex VirusesNew England Journal of Medicine, 1986
- Protection from Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein DScience, 1985
- Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent DiseaseThe Journal of Infectious Diseases, 1982